MAYBAKER Stock Overview
May & Baker Nigeria Plc manufactures, sells, and distributes human pharmaceuticals, human vaccines, and consumer products in Nigeria.
+ 1 more risk
May & Baker Nigeria plc Competitors
Price History & Performance
|Historical stock prices|
|Current Share Price||₦3.76|
|52 Week High||₦5.45|
|52 Week Low||₦3.35|
|1 Month Change||-4.08%|
|3 Month Change||-3.09%|
|1 Year Change||-16.26%|
|3 Year Change||83.41%|
|5 Year Change||38.75%|
|Change since IPO||180.75%|
Recent News & Updates
|MAYBAKER||NG Pharmaceuticals||NG Market|
Return vs Industry: MAYBAKER underperformed the NG Pharmaceuticals industry which returned 15.8% over the past year.
Return vs Market: MAYBAKER underperformed the NG Market which returned -1.2% over the past year.
|MAYBAKER Average Weekly Movement||6.4%|
|Pharmaceuticals Industry Average Movement||4.3%|
|Market Average Movement||5.5%|
|10% most volatile stocks in NG Market||6.9%|
|10% least volatile stocks in NG Market||2.8%|
Stable Share Price: MAYBAKER is more volatile than 75% of NG stocks over the past 3 months, typically moving +/- 6% a week.
Volatility Over Time: MAYBAKER's weekly volatility (6%) has been stable over the past year, but is still higher than 75% of NG stocks.
About the Company
May & Baker Nigeria Plc manufactures, sells, and distributes human pharmaceuticals, human vaccines, and consumer products in Nigeria. It operates through Pharmaceuticals and Beverage segments. The company offers pharmaceuticals, including anti-diabetic; anti-hypersensitive; anti-infective; anti-malaria; analgesic; cough and cold; anxiolytics; and nature care products.
May & Baker Nigeria plc Fundamentals Summary
|MAYBAKER fundamental statistics|
Is MAYBAKER overvalued?See Fair Value and valuation analysis
Earnings & Revenue
|MAYBAKER income statement (TTM)|
|Cost of Revenue||₦10.51b|
Last Reported Earnings
Sep 30, 2022
Next Earnings Date
|Earnings per share (EPS)||0.93|
|Net Profit Margin||11.26%|
How did MAYBAKER perform over the long term?See historical performance and comparison